NCT05917210 Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
| NCT ID | NCT05917210 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Tuberculosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,920 participants |
| Start Date | 2026-03-16 |
| Primary Completion | 2028-04-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,920 participants in total. It began in 2026-03-16 with a primary completion date of 2028-04-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This cluster-randomized trial in Uganda will evaluate the effectiveness and implementation of a novel, peer-led TB education and counseling strategy to improve outcomes among persons with tuberculosis (TB) with and without HIV/AIDS and assess the social-behavioral mechanisms underlying the observed treatment effects.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Registered as a new, relapse, treatment failure, or previously lost-to-follow-up * TB case according to the on-site NTP TB Treatment Register * Screened and invited to participate within 30 days of TB treatment initiation Exclusion Criteria: * Diagnosed with possible or confirmed drug-resistant TB * Transferring TB care into the clinic from an off-site facility * Residing \>40 km from the enrolling clinic * Lacking mental capacity to provide informed consent
Contact & Investigator
J. Lucian Davis, MD, MAS
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT05917210 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tuberculosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05917210 currently recruiting?
Yes, NCT05917210 is actively recruiting participants. Contact the research team at Lucian.Davis@yale.edu for enrollment information.
Where is the NCT05917210 trial being conducted?
This trial is being conducted at Kampala, Uganda.
Who is sponsoring the NCT05917210 clinical trial?
NCT05917210 is sponsored by Yale University. The principal investigator is J. Lucian Davis, MD, MAS at Yale University. The trial plans to enroll 1,920 participants.